Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-11-15

Clinical Trial Update: Use of Amnion on Partial Thickness Burns [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial investigating the use of amnion (amniotic membrane) on partial-thickness burn injuries has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amnion (amniotic membrane) (amniotic membrane)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Burn | Phase 2, Phase 3 | Status: WITHDRAWN